University of Calgary

University / College


Location: Calgary, Canada (CA) CA

ISNI: 0000000419367697

ROR: https://ror.org/03yjb2x39

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Sclerosing mucoepidermoid carcinoma of salivary glands (2024) Othman BK, Bradová M, Simpson RH, Laco J, Agaimy A, Rito M, Ihrler S, et al. Journal article Neural network and layer-wise relevance propagation reveal how ice hockey protective equipment restricts players’ motion (2024) Lennartz R, Khassetarash A, R. Nigg S, Eskofier B, Nigg BM Journal article Hybrid Teamwork: What We Know and Where We Can Go From Here (2024) Handke L, Aldana A, Costa PL, O’Neill TA Journal article Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials (2024) Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, et al. Journal article Evaluation of a medical student-delivered smoking prevention program utilizing a face-aging mobile app for secondary schools in Germany: The Education Against Tobacco cluster-randomized controlled trial (2024) Brinker TJ, Krieghoff-Henning EI, Suhre JL, Silchmüller MP, Divizieva E, Wilhelm J, Hillebrand G, et al. Journal article Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma (2024) Saner FA, Takahashi K, Budden T, Pandey A, Ariyaratne D, Zwimpfer TA, Meagher NS, et al. Journal article Correction: Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals (European Journal of Human Genetics, (2024), 32, 8, (928-937), 10.1038/s41431-024-01610-1) (2024) Layo-Carris DE, Lubin EE, Sangree AK, Clark KJ, Durham EL, Gonzalez EM, Smith S, et al. Journal article, Erratum Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (2024) Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D’Haens G, Ferrante M, Schreiber S, et al. Journal article Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage (2024) Connolly SJ, Sharma M, Cohen AT, Demchuk AM, Członkowska A, Lindgren AG, Molina CA, et al. Journal article Differences in running technique between runners with better and poorer running economy and lower and higher milage: An artificial neural network approach (2024) Van Hooren B, Lennartz R, Cox M, Hoitz F, Plasqui G, Meijer K Journal article